Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
The Conversation logo

Over the past few weeks, the UK government has gradually eased national lockdown measures. As the economy reopens, and people return to workplaces and spend more time in shops, pubs and restaurants, the number of contacts an individual has with other people will inevitably increase.

Since then, there has been an increase in COVID-19 cases following the lowest recorded estimate in June, as well as spikes in transmission in certain areas. In response, rather than locking down the whole country again, the government has brought in local lockdowns in affected areas.

National lockdown has a significant indirect effect on people’s health: fewer people go to hospital emergency departments when needed and vaccination and cancer screening programmes are delayed. Local lockdowns, therefore, aim to control the spread of the virus in a specific area in response to a local spike of infections. They may be the best option we have for managing the pandemic prior to a vaccine becoming available.

Read the full article on The Conversation website, written by Lakshmi Manoharan, Centre for Tropical Medicine & Global Health.

Oxford is a subscribing member of The ConversationFind out how you can write for The Conversation.

Similar stories

Study reveals ‘stop-eating’ response to DNA damage

A new study from the MRC Weatherall Institute of Molecular Medicine sheds light on the mechanism by which DNA damage suppresses appetite, a finding with implications for understanding the appetite lowering side-effects of chemotherapy.

Fiona Powrie appointed new Deputy Chair of Wellcome’s Board of Governors

Fiona Powrie, Director of the Kennedy Institute of Rheumatology at the University of Oxford has been selected as the next Deputy Chair of Wellcome’s Board of Governors.

World’s first cancer prevention trial to test diabetes drug in patients with high-risk genetic condition

Oxford researchers will lead a £2m national cancer prevention trial to assess the benefit a diabetes drug has in patients with Li Fraumeni Syndrome (LFS), a genetic condition that impacts 1 in 20,000 people worldwide and puts them at a 70-90% lifetime risk of cancer.

One high altitude explorer acknowledges another

NASA Astronaut and Physiologist Dr Jessica Meir unveils The Physiological Society blue plaque in honour of fellow pioneering Physiologist and Scientific Explorer Mabel FitzGerald.

Oxford-led research maps milestone stage of human development for the first time

Scientists have shed light on an important stage of early embryonic development that has never been fully mapped out in humans before.